ERAS - Erasca - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

39.66M

Cash

317.2M

Avg Qtr Burn

-25.66M

Short % of Float

9.74%

Insider Ownership

22.29%

Institutional Own.

63.51%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Naporafenib (pan-RAF inhibitor) w/ trametinib Details NRASm melanoma, Melanoma	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Naporafenib (pan-RAF inhibitor) w/ trametinib Details Solid tumor/s, RAS Q61X solid tumors	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ERAS-601 (SHP2 inhibitor) Details Solid tumor/s, Cancer, Head and neck squamous cell carcinoma	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ERAS-007 Details Cancer, Gastrointestinal stromal tumors, Advanced malignancies, Colorectal cancer , BRAFm Colorectal Cancer	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ERAS-801/EGFR inhibitor Details Cancer, Glioblastoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ERAS-007 Details Non-small cell lung carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ERAS-007 + ERAS-601 Details Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.